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ABSTRACT: Recently, special attention has been given to the possible 
neuroprotective effects of lithium, especially by the discovery of its 
regulatory effects on pro and anti-apoptotic proteins. Lithium substantially 
increases the cytoprotective proteins expression in the central nervous 
system, both in rat cortex and in human cells of neuronal origin. In addition 
to neuroprotective actions, it aids in the regeneration of axons in the central 
nervous system of mammals. Lithium negatively regulates the expression 
and activity of enzymes that exert important functions in cerebral 
homeostasis: synaptic plasticity, neurogenesis, and phosphorylation of 
tau protein. Microglia is known for its importance in neuropathology. 
However, under physiological conditions, such immune cells interact 
actively with neurons, being able to modulate the fate and functions of 
the synapses. Such ability of microglial cells suggests the consequences 
of changes in microglial phenotype under pathological conditions, which 
makes it relevant to understand the interaction between microglial and 
other developing brain cells and their influence on the formation of 
neuronal and synaptic networks. The current work aims to identify the 
main pathway of neuronal-glia integration activated by chronic treatment 
with lithium in neurons, exploring the use of bioinformatics tools in 
microarray data. Treatment of primary hippocampal neurons with lithium 
changed the genes related to different neuroprotection pathways at the 
highest therapeutic dose. There was dissociation between the therapeutic 
and sub-therapeutic dose of lithium in neuroprotection. Therefore, 
treatment at therapeutic doses (2mM) modified different signaling 
pathways when compared to the sub-therapeutic dose (0.02 and 0.2mM).
Keywords: Neuroprotection; Hippocampus; Lithium; Neuroglia; 
Neurons.
RESUMO: Recentemente, especial atenção foi dada aos possíveis efeitos 
neuroprotetores do lítio, especialmente pela descoberta de seus efeitos 
regulatórios sobre proteínas pró e anti-apoptóticas. O lítio aumenta 
substancialmente a expressão de proteínas citoprotetoras no sistema 
nervoso central, tanto no córtex de ratos quanto em células humanas de 
origem neuronal. Além de ações neuroprotetoras, auxilia na regeneração 
de axônios no sistema nervoso central de mamíferos. O lítio regula 
negativamente a expressão e a atividade de enzimas que exercem funções 
importantes na homeostase cerebral: plasticidade sináptica, neurogênese 
e fosforilação da proteína tau. Microglia é conhecida por sua importância 
na neuropatologia. No entanto, sob condições fisiológicas, tais células 
imunes interagem ativamente com os neurônios, sendo capazes de 
modular o destino e as funções das sinapses. Essa capacidade das células 
microgliais sugere as conseqüências de mudanças no fenótipo microglial 
sob condições patológicas, o que torna relevante o entendimento da 
interação entre micróglia e outras células cerebrais em desenvolvimento 
e sua influência na formação de redes neuronais e sinápticas. O presente 
trabalho tem como objetivo identificar a principal via de integração 
neurônio-glia ativada pelo tratamento crônico com lítio em neurônios, 
explorando o uso de ferramentas de bioinformática em dados de 
microarray. O tratamento de neurônios hipocampais com lítio alterou os 
genes relacionados a diferentes vias de neuroproteção na dose terapêutica 
mais alta. Houve dissociação entre a dose terapêutica e sub-terapêutica 
de lítio na neuroproteção. Portanto, o tratamento em doses terapêuticas 
(2mM) modificou diferentes vias de sinalização quando comparado com 
as doses sub-terapêuticas (0,02 e 0,2mM).
Descritores: Neuroproteção; Hipocampo; Lítio; Neuroglia; Neurônios.
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INTRODUCTION 
Alzheimer’s disease 
Alzheimer’s disease (AD) is the most frequent 
progressive neurodegenerative disease associated with age, 
whose cognitive and neuropsychiatric manifestations result 
in a deficiency progression and eventual incapacitation1. 
The disease affects more than 30 million individuals 
throughout the world2.
In general, the first clinical aspect is the recent 
memory deficiency, which can affect the processes of 
learning, reasoning and attention. With the evolution 
of the disease, there is a progressive loss of judgment, 
language, orientation and other cognitive abilities. The 
individual with AD may not be able to report symptoms 
of other diseases, follow prescribed treatment and report 
side effects of medicines. In the final stages of the disease, 
brain changes begin to affect physical functions, such as 
swallowing, balancing, and controlling urination, which 
increases vulnerability to other health problems, namely: 
aspiration, pneumonia, falls, fractures, malnutrition and 
dehydration.
The pathogenic process of AD involves different 
mechanisms of neurodegeneration in different brain 
regions: initially in the medial portions of the temporal 
lobe - hippocampus and cortex entorhinal3 - later in other 
brain regions responsible for cognitive functions as limbic 
structures and associative cortices4. Parallel to neuronal 
loss, occur extracellular deposit - which main component is 
amyloid beta peptide (AB) - and intracellular accumulations 
of neurofibrillary tangles of the hyperphosphorylated Tau 
protein. These AB peptide deposits and neurofibrillary 
tangles are the histopathological characteristics of the 
disease.
Microglia
Microglia are immune cells of the central nervous 
system (CNS), which guarantee tissue homeostasis, mediate 
the defense against pathogens and constitute the sentinel 
immune network5,6,7. Unlike other tissue macrophages, the 
microglia do not originate from a monocyte progenitor, 
but derive from a macrophage lineage of the sac primitive 
yolk8. In addition, the microglia are distinct from the 
myeloid cells which may infiltrate the nervous system under 
inflammatory conditions9. As specialized macrophages, 
microglia actively support and protect the neuronal 
environment.
Microglia perform various functions in the CNS 
of the healthy adult: patrol the brain to detect pathogens, 
contribute to neuronal health at synapses, modulate synaptic 
transmission, and promote neurogenesis. Under normal 
conditions, microglia actively monitor their environment 
with projections10, with the ability to react immediately to 
homeostasis imbalances.
It has been suggested that, under small disturbances, 
the microglia provide trophic support and protection11. 
Infection, neurodegeneration, and other conditions 
associated with loss of homeostasis, induce changes in 
microglial morphology, gene expression and function 
- referred generically as “activation”5,6,7,12. Activated 
microglia stimulate phagocytic activity, release chemokines 
and neurotrophic factors and present T-cell antigens6.
Microglia and Alzheimer’s disease
There is no consensus on the contribution of the 
systemic immune response and the recruitment of monocyte 
and tissue-resident microglia for the onset and progression 
of AD13-18. Some studies have shown that, under certain 
conditions, microglia acquire proinflammatory activity, 
which was associated with the evolution of the disease19,20.
The debate regarding the involvement of microglia 
as a response to brain pathologies exists because of 
technical limitations in the analysis of heterogeneous 
cellular populations, which make it difficult to define 
the cellular immune types involved in the homeostasis 
and pathology of the brain. As a result, several innate 
immune functions were attributed either to microglia or 
to the monocyte infiltrated into the blood. For example, in 
AD, as well as in other neurodegenerative diseases, local 
inflammation associated with cytotoxicity or with the 
evolution of the disease has often been attributed mainly to 
microglia20,21,22. In contrast, several studies have attributed 
an important role to monocytes in the clearance of brain 
toxins17,23,24.
New studies involving sequencing single cell RNA 
in isolated brain immune cell samples identified a protective 
subtype of microglia, microglia associated with disease 
(MAD) and their dynamics during the progression of AD. 
Through immunohistochemistry, this subtype of microglia 
was associated to brain areas affected by the disease. More 
detailed analysis of genes expressed by MAD revealed an 
increase in lipid metabolism pathways and in the expression 
of genes related to phagocytosis, corresponding, though, to 
the need for deboning the entanglements in AD.
Immunomodulation between MAD-specific genes 
and AB peptide identified an improvement in phagocytic 
activity of MAD cells and a maintenance of their function 
in the brains of mice and humans. Genomic analysis of 
post-mortem brains of patients with AD and corresponding 
non-DA controls will allow the identification of the role 
of MAD in AD and reveal greater immune heterogeneity.
It is possible, therefore, that there is a compensation 
in the cerebral homeostasis between the numbers of MAD 
cells with phagocytic activity and the mechanisms of 
control with inhibitory signaling on this cellular subtype. 
Such control mechanisms, while essential for microglial 
function to ensure their immune activation can become a 
negative factor when strong phagocytic activity is needed 
- as in aging or under neurodegenerative diseases.
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Microglia and lithium
As suggested, the sustained reactivity of microglia 
is implicated in the pathology of many neurodegenerative 
diseases and an increase in its reactivity may lead to 
apoptosis25-28. Apoptotic microglia impairs the CNS 
protection and its repair function, and has been found in 
several neurological diseases, such as AD29,30. P53 is a 
transcription factor whose alteration promotes apoptosis 
through the normal cell cycle, particularly during the 
enhancement of neural networks in the development. 
P53 also activates the expression of genes involved in 
stress-induced apoptosis and the apoptotic pathways 
involved in neurodegenerative diseases31-33 that may 
arise from inappropriate activation of p5334,35. Changes 
in p53 expression occur in the glial cells in neurological 
conditions: p53 expression increases predominantly in glial 
cells in AD36. Also, positive regulation of p53 in AD can 
induce Tau phosphorylation28, which allows to establish a 
relationship between p53, microglial activation, apoptosis 
and neurodegenerative disease.
In this context, treatment with lithium chloride 
may decrease both levels of messenger RNA (mRNA) 
and p53 transcripts in cultured neurons. Exposure of the 
microglial (5 mM) for 24 hours before the microglial 
activation significantly reduced the expression induced 
by activation of p53 in the primary microglia. In addition, 
the lithium chloride directly inhibits the serine / threonine 
kinase and the glycogen synthase kinase-337, whose 
activation has pleiotropic effects, including those in p53 
and apoptosis38. At concentrations of 0.1-10 mM lithium 
chloride was observed an increase in the number of 
microglial cells in mixed neuronal-glial cultures. Treatment 
with lithium can reduce microglial activation39 and promote 
a neuroprotective microglial phenotype40. In summary, 
these findings suggest that the prevention of microglial 
and posterior stress apoptosis and the maintenance of 
its proliferation capacity is therefore neuroprotective. 
Inhibition of p53 prevented the expression of apoptotic 
markers induced by peptide AB.
In addition to its effect on p53 expression, further 
research has demonstrated the effects of treatment with 
lithium on the production of cytokines in differentiated 
monocytes, such as microglia. The microglia produces 
the third component of the complement system (C3) 
and expresses the C3 receptors41 and is involved in 
synaptic elimination because of the expression of these 
proteins42. It has been suggested that the therapeutic 
concentration of lithium modulates neuronal connectivity 
and neuroprotective effects on the human brain43, inducing 
the production of C3 and pointing to C3 as a biomarker of 
peripheral dendritic cells and microglia in the CNS.
Maturation of neuron / glia
Microglia is known, mainly, for its role in 
neuropathology. However, such immune cells interact 
actively with neurons under physiological conditions, 
being able to modulate Synaptic functions. Originated 
from myeloid precursors of the yolk sac, microglial cells 
invade the CNS during early embryonic development, and 
may influence the proliferation, migration and neuronal 
differentiation, as well as the formation of mature neural 
networks thus contributing to the development of the 
CNS. These microglial cells are involved in crucial 
stages of neuronal survival and apoptosis, axonal growth, 
neuron migration, supernumerary synapses and functional 
maturation of developing synapses.
During their monitoring of the cerebral parenchyma, 
the microglial cells process the contact of the synapses. The 
occurrence and duration of these contacts are regulated by the 
activity of the neural network and can influence the fate and 
activity of the synapses44,45,46. These observations suggest 
that changes in the microglial phenotype in pathological 
conditions will have the following consequences: the loss 
of the constitutive influence of topographical microglia and 
the emergence of new interactions with the immune nature 
of these cells. It becomes relevant, therefore, to understand 
the interaction between microglia and other developing 
brain cells and their influence on formation of neural and 
synaptic networks.
In primary cultures of mesencephalic and cortical 
embryonic neurons, the microglial medium increases 
the absorption of neurotransmitters and the number of 
mature neurons. This suggests that the microglial cells 
have a neurotrophic effect through the release of factors, 
probably derived from plasminogen47. Microglia purified 
from brain of embryo rat promotes the proliferation of 
cultured neuronal cells by releasing the extracellular 
matrix - thrombospondin48. Thrombospondin is also highly 
expressed by astrocytes and promotes synaptogenesis.
The discovery of microglial cells that regulate 
synapses under physiological conditions has changed the 
importance of these cells in CNS physiology and motivates 
studies. The ability of these immune cells of remodeling 
its phenotype according to environmental changes makes 
them the most plastic cells of the CNS.
ACADEMIC CONTRIBUTION
In summary, AD is an age-related neurodegenerative 
disease characterized by progression of memory and 
cognitive dysfunction, manifested histologically with 
parenchymal deposition of AB peptide, neurofibrillary 
tangles formation and neuroinflammation. It has been 
highlighted the role of some cells of the brain defense 
system, such as microglia, in the pathophysiology of AD 
and in the influence on the progression of the disease. 
However, there is no consensus among the specific 
contribution of microglia in these processes. Select genes 
related to neuron-glia interaction and verify the operation 
of these selected genes in culture of lithium-treated 
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hippocampal neurons could reveal signaling pathways 
and provide a better understanding of the neuroprotection 
pathway in the neuroinflammation of AD.
OBJECTIVES
The objective of this research is to determine in 
the literature genes related to the neuroprotection of the 
neuronal-glia interaction. After identifying the genes, to 
analyze the influences of different doses of lithium on 
cellular processes pathways.
Specific objectives
1. To identify, according to data in the literature, 
genes of neuron-glia interaction present in AD;
2. Analyze the genes in the microarray data and 
compare lithium treatment (0.02mM; 0.2mM and 
2mM) with the control condition (no treatment 
with lithium).
3. Identify the signaling pathways present in the 
different treatment doses of the cell cultures 
with lithium.
MATERIAL AND METHODS
Primary cultures of neurons
Hippocampal neurons cell culture
Cultures of post mitotic neurons from rat embryos 
were obtained according to the following protocol. Wistar 
rats provided by the Center of Faculty of Medicine of 
the University of São Paulo (FMUSP) were sacrificed on 
the 18th day of gestation, thus obtaining embryos of the 
desired age (E18).
The method used for induction of death was 
guillotine. After abdominal alcohol asepsis diluted in water 
(70% v/v), using sterile surgical instruments and gloves, 
the uterine sac containing their embryos (usually 10 to 16) 
was extracted by laparotomy. Then it was conditioned in 
a sterile Petri dish and taken to a laminar flow chamber, 
where tissue dissection followed, in an aseptic environment. 
After removal of the gestational membranes, the fetuses 
obtained were submitted to occipitofrontal craniotomy - the 
respective brains were removed and packed in sterile petri 
dish. The brains were immersed in Neurobasal medium 
solution (Gibco) containing penicillin and streptomycin, 
20mM glutamine and supplement B-27 (Gibco) heated 
to 37°C. Because of the large number of brains to be 
dissected, and the time required for this procedure, half of 
the brains were kept in a 5% CO2 perfused oven at 37ºC, 
while hippocampal of the other half was dissected, in order 
to preserve the viability of the dissected tissues after time 
of procedure.
The dissection steps were done under a medium 
magnifying glass (40
Є
), using microsurgical instruments. 
The cerebral hemispheres were separated, the membranes 
removed and then the dissection of hippocampal 
formations. The tissues obtained were reduced to smaller 
fragments (approximately 1mm3), transferred to the test 
tube, the HBSS solution was removed, and trypsin solution 
(0.5 mg/mL in HBSS) was added for 20 minutes in a water 
bath at 37°C.
After incubation, the fragments of nerve tissue 
were washed again three times in 5mL of Hanks solution 
containing additives (HBSS +), namely: magnesium 
chloride 8mM (MgCl2 .6H2O) (Sigma), serum 5% (v/v) 
inactivated equine (Sigma), 10mM Hepes buffer (Gibco) 
and 1μg/ml deoxyribonuclease (DNase I).
The tissue fragments were dissociated by hydro 
mechanical action in 2-4 mL of HBSS +. To do this, two 
Pasteur glass type pipettes were used successively, with 
their respective passage reduced by fire to approximately 
1.0 and 0.5mm in diameter. Suspension of isolated cells 
was then obtained by dissociating the tissue fragments, 
aspirating it with the aid of a bulb of the opposite end of 
the pipette, and exhausting its contents repeatedly (20 to 30 
times with each pipette) until a cloudy and homogeneous 
solution is obtained with the naked eye.
For counting and evaluating cell viability, a 10uL 
aliquot of this suspension was withdrawn and diluted 20-
fold in solution containing 90μL of HBSS and 100μL of 
Trypan blue dye. A 10μL aliquot of this new solution was 
transferred to a hemocytometer (Neubauer chamber), under 
a glass cover, and observed in a magnifying microscope 
100 (Eclipse E200®; Nikon), with an objective lens of 
10 magnification. It was made an average estimate of the 
number of uncolored cells in the four fields of the counting 
chamber. Each field has an area of 1mm2 (corresponding to 
the set of 16 squares whose sides measure 0.25 mm) and 
gives a number of cells in 10-4 mL of suspension. Multiply 
the number obtained in the count by the respective dilution 
factor (number x 20 x 10-4), thus inferring the approximate 
number of viable cells per milliliter of the cell suspension.
For the preparation of the culture vessels, Petri 
dishes (Sarstedt Cell +) made in treated sterilized 
polystyrene ready to use; and for the sensitization of 
the culture wells, polyd-lysine (PdL). Two days prior to 
dissection, 5μg/mL PdL solution was applied in sterile 
deionized water, in sufficient volume to cover the culture 
surface. The PdL solution was maintained for two days and 
removed just prior to seeding the cell suspension.
The cell suspension was diluted in growth medium 
at the ideal density of 1.0 or 1.5x105 cells/mL, for 
immediate seeding in culture vessels. Using Petri dishes, 
5mL of the cell suspension was discharged into each well, 
thus reaching a density of approximately 1.5x105 cells per 
cm2 of culture surface. The usual yield of the procedure is 
approximately 500,000 cells per hippocampus - from 1.0 to 
1.5x105 cells per animal. Despite the low need of neurons 
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for oxygen, the survival of the cells is a function of the 
total time of the procedure, which should not exceed two 
hours, from the sacrifice of the animal to the sowing and 
conditioning of the cultures in the incubator.
Cultures were maintained at 37°C in a humidified 
air-CO2 incubator (5% v/v). As a growth medium, 
Neurobasal medium plus 0.1mM l-glutamine (Gibco 
25030-024), antibiotics (50 IU/ml penicillin solution and 
50 μg/ml streptomycin), and B-27 supplement (Gibco 
17504-036) (1:50 v/v).
In the first 24 hours in culture only, the growth 
medium was enriched with fetal bovine serum (FBS). On 
the second day of incubation, the growth medium was 
replaced in its entirety by means of fresh culture without 
FBS. Thereafter half the volume of supernatant from 
each culture well was changed every 48-72 hours to fresh 
means; always without FBS. Low density hippocampal 
neurons tend to degenerate rapidly if the growth medium is 
completely changed, since the secreted factors by glial cells 
present in culture are required for neuronal development 
and survival.
Treatments
Cells were treated with ClLi (Lithium Chloride) at 
concentrations of: 0.02 mM, 0.2 mM and 2 mM for 7 days. 
All samples were compared with the control condition, 
that is, condition without administration of the drug. The 
treatment started on the fourth day in culture until the 
tenth day.
Microarray Analysis
Cultures were carried out in a 6-well petri dish, with 
20 plates for each treatment (control, 0.02mM, 0.2mM and 
2mM). At the end of the culture the RNA was extracted by 
RNeasy Mini Kit (Quiagen).
This kit allows to extract RNA from a small 
number of cells (maximum of 5x105). Briefly, the cells 
are lysed and the RNA is bound to the silica membrane 
of the column. Following is a treatment with DNase I to 
remove traces of genomic DNA. RNA was eluted with 
RNase-free water. The RNA concentration was determined 
spectrophotometrically using Nanodrop.
The quality of the samples was determined by the 
Agilent 2100 Bioanalyser (Agilent Technologies, U.S.A.) 
through the RNA Integrity Number (RIN) obtained 
by the Agilent RNA 6000 Pico and Nano Kit (Agilent 
Technologies, U.S.A.) according to the amount of sample. 
This platform allows the analysis of samples of RNA on 
a chip through capillary electrophoresis. Samples are 
considered good when RINs are with values equal to or 
greater than 7. After determining their concentration and 
quality, the RNA was stored at -80°C.
Bioinformatics Analysis
For the formation of PPI (Protein protein interaction) 
networks we will consult three databases of human 
interatomic: HPRD49, MINT50 and Intact51. We will do 
a cut-out of this network comprising up to the second 
neighbors from the genes selected from the literature. We 
will look for in the literature public data of microarray 
comparing cases and controls in the hippocampus. To 
assess the difference in co-expression of the differentially 
expressed in the microarray, we will perform an analysis of 
gene co-expression networks. The correlation of each gene 
and its partners will be calculated by Pearson’s Coefficient 
of Correlation (PCC). Differences in PCC between groups 
will be compared to 1000 lists of coexpression differences 
mixing cases and controls, that is, 1000 random sets 
(p-value ≤ 0.05). We will also use the WGCNA tool52 to 
search for co-expression module.
The network will be viewed using Cytoscape53. We 
will analyze the differences topological properties of gene 
networks seeking to prioritize AD-related partners and to 
compare findings in the hippocampus. For identification 
of broker and bridge genes, we will use the Interatomic 
Graph website (http://bioinfo.lbhc.hcancer.org.br/
interactomegraph).
Methods of analysis
The data will be analyzed in software R or SPSS 18. 
Publication Search
A systematic literature search was conducted in 
PubMed databases up to April 11, 2018. The combination of 
terms “neuronal”, “glia” and “interactions”, “cell culture”, 
“gene interactions”, “lithium influence” was used with 
language restriction - English - and publication date (from 
2013 only). Relevant studies were retrieved, and their 
references were checked to find other relevant publications. 
The inclusion criteria were: (1) evaluation of the 
association between neuronal glia and genes interactions, 
lithium influence and interactions cell cultures; (2) studies 
with animals; (3) RNA/DNA analysis. The exclusion 
criteria were: (1) protein analysis only; (2) studies with 
humans. 
ETHICAL ASPECTS
The approval by the Ethics Committee of the 
Hospital was obtained before beginning of the studies 
described in this plan, which are part of the Regular Project 
CNPQ 2009 / 52825-8, entitled “Expression and activity of 
APP-secretases and GSK3B in human platelets and cultures 
effects of treatment with donepezil and lithium “.
Handling and slaughter of animals shall be 
conducted in accordance with the principles set in the 
“Guide for the care and use of laboratory animals”(ISBN 
0-309-05377-3), National Institute Health (NIH publication 
No. 86-23, revised 1985).
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RESULTS
Microarray Analysis 
It was obtained from microarray analysis: 44 genes 
at 0.02mM; 1256 genes at 0.2mM and 2396 genes at 2 mM 
of Lithium treatment. To identify the genes differentially 
expressed in relation to the control condition, the t test and 
corrected by Bonferroni.
Literature Search and Database Analysis
Following the criteria, were found:
- “Neuronal glia interactions cell culture”: 50 articles
in the last 5 years;
- “Neuronal glia genes interactions”: 25 articles in
the last 5 years;
- “Lithium neuronal glia interactions”: 4 articles in
the last 5 years;
Article Specie/Model Biological  matrix
Drug 
treatment
Experiment Selected genes
Kangas SM, et al., 
2016 
 13.5‐day‐old mouse 
embryos Mice 
(C57BL/6JOlaHsd, 
Harlan Holland) 
Dorsal root 
ganglions ___
Hybridization Kit (Agilent) into 
SurePrint G3 (Mouse GE 8 x 
60K arrays (Agilent, Design ID 
028005). 
6 genes: Ngfr, Pou3f1 Nefm 
Mag, Mpz , Mbp
Emamghoreishi M, et 
al., 2015
18-day embryos of
Sprague-Dawley rats
Embryonic 
cortices
1mM 
Lithium
PCR  2 genes: S100ß and GAPDH
Chen SH, et al., 2015
Timed-pregnant Fisher 
344 rats at day 14 of 
gestation
Cortices and 
midbrain
___ PCR
7 genes: GDNF F2, BDNF 
F1, GAPDH F2, TNFalfa 
F4, Inos F1, INOS R1, 
GDNF R2
Yang J, et al., 2014 P0 or P1 Adult male 
Sprague–Dawley rats 
Hippocampi ___ PCR
6 genes: GAPDH, ephrin 
A1,ephrin A2,ephrin A3, 
ephrin A4, ephrin A5
- “Lithium influence in Neuronal glia”: 1 article in
the last 5 years;
- “Lithium influence in Neuronal glia interactions”:  0
article in the last 5 years.
From the remaining articles, the abstracts were read 
and, again, more articles were filtered. To compose the 
references to the work, the last filter was the reading of 
the whole material and methods. In short: search for the 
descriptors → reading the titles → reading the abstracts → 
reading the material and methods → obtaining the articles 
to be used in the review. 
The search of databases retrieved many articles 
giving a total of 80 relevant titles and abstracts for review. 
A further unrelated 52 articles were excluded based on 
abstracts. After a material and methods review, 4 studies 
remained54-57. The main characteristics of these eligible 
studies and the selected genes are listed in Tables 1 and 2. 
Table 1. Characteristics of the eligible studies
Table 2. Selected genes
Gene Name Gene ID Rattus norvegicus
Ngfr 24596
Pou3f1 192110
Nefm 24588
Mag 29409
Mpz 24564
Mbp 24547
S100ß 25742
GAPDH 24383
Ephrin A1 94268
Ephrin A2 84358
Ephrin A3 170901
Ephrin A4 310643
Ephrin A5 116683
The following genes GDNF F2, BDNF F1, GAPDH 
F2, TNFalfaF4, INOS F1, INOS R1, and GDNF R2 were 
excluded because it was not found relation with Rattus 
norvegicus organisms.
The remained selected genes were translated into 
biological pathways using WebGestalt (WEB-based Gene 
SeT AnaLysis Toolkit) - a functional enrichment analysis 
web tool (http://www.webgestalt.org/option.php). For 
this study, the basic parameters were Rattus norvegicus 
for organisms, Over-Representation Analysis (ORA) 
as method for enrichment analysis, gene ontology for 
functional database class and biological process, cellular 
component and molecular function for functional database 
categories. For the gene list showed above, their main 
related biological pathways plotted in charts are presented 
in Figures 1, 2 and 3.
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Fonte: http://www.webgestalt.org/option.php
Figure 1. Biological process categories
Fonte: http://www.webgestalt.org/option.php
Figure 2. Cellular components categories
Fonte: http://www.webgestalt.org/option.php
Figure 3. Molecular function categories
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In addition, these genes were submitted to STRING, 
a functional protein association networks analysis web 
tool (https://string-db.org/). With this database of known 
and predicted protein-protein interactions, including 
direct (physical) and indirect (functional) associations 
from computational prediction, from knowledge transfer 
between organisms, and from interactions aggregated from 
other (primary) databases, it was obtained a grown network. 
Results with no more than 50 interactions between the 
genes selected from literature and the genes from STRING 
database are presented in Figure 4.
The remained total genes are listed in Table 3.
Fonte: https://string-db.org/
Figure 4. Grown network with no more than 50 interactions
Table 3. Total selected genes
Gene Name Gene ID Rattus norvegicus
Efna1 94268
Tpi1 24849
Eno1 24333
Epha3 29210
Epha4 316539
Pgk2 316265
Eno-2 24334
Eno3 25438
Gapdh 24383
RGD1560402 499525
Ephb3 287989
Efna2 84358
Ephb4 686310
Efna5 116683
RGD1562679 298528
Mag 29409
Epha1 312279
Efna4 310643
Ngf 310738
Epha2 366492
Ephb2 313633
Ephb1 24338
Ngfr 24596
Mbp 24547
Pgk1 24644
Epha7 171287
Rtn4 83765
Ephb3 287989
S100b 25742
Mpz 24564
Bdnf 24225
Eno4 292138
Ntf3 81737
Epha10 298528
Lingo 1 315691
Sort 1 83576
Ntf4 25730
Omg 450224
Ripk2 362491
Gfap 24387
Src 83805
Epha5 79208
Epha8 60589
RGD1559534 287338
Fyn 25150
For these second gene list showed above, their 
main related biological pathways, according to WebGestalt 
database, plotted in charts are presented in Figures 5, 6 
and 7. The basic parameters were Rattus norvegicus for 
organisms, Over-Representation Analysis (ORA) as method 
for enrichment analysis, gene ontology for functional 
database class and biological process, cellular component 
and molecular function for functional database categories.
Comparative Results
The total genes and the genes from microarray 
analysis for each treatment with Lithium (0.02mM, 0.2mM 
and 2mM) were compared using a Venn’s diagram drawing 
web tool (http://bioinfogp.cnb.csic.es/tools/venny/). The 
result for the four lists of elements is presented in Figure 8.
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Fonte: http://www.webgestalt.org/option.php
Figure 5. Biological process categories
Fonte: http://www.webgestalt.org/option.php
Figure 6. Cellular component categories
Fonte: http://www.webgestalt.org/option.php
Figure 7. Molecular function categories
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Fonte: http://bioinfogp.cnb.csic.es/tools/venny/
Figure 8. Compared lists of genes with Venn diagram
It were found 6 common elements in “Neuron-Glia” 
and “2 mM Li”: Efna2, Efna4, Omg, Ngfr, Mbp, S100b.
The main related biological pathways with the genes 
above, according to WebGestalt database, plotted in charts 
are presented in Figures 9, 10 and 11. The basic parameters 
were Rattus norvegicus for organisms, Over-Representation 
Analysis (ORA) as method for enrichment analysis, gene 
ontology for functional database class and biological 
process, cellular component and molecular function for 
functional database categories.
Fonte: http://www.webgestalt.org/option.php
Figure 9. Biological process categories
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Fonte: http://www.webgestalt.org/option.php
Figure 10. Cellular component categories
Fonte: http://www.webgestalt.org/option.php
Figure 11 - Molecular function categories
DISCUSSION
We analyzed 4 articles in order to identify genes 
related to the neuroprotection and the neuronal-glia 
interaction. These data were used to compare with the ones 
obtained from the microarray analysis, which includes the 
genes differentially expressed after a treatment with 0.02, 
0.2 and 2mM doses of Lithium, to identify if there is any 
influence of these doses of treatment into the neuronal-glia 
interactions pathways. 
The main related biological pathways with the genes 
found in the selected articles were Biological Regulation 
(11.6%), Membrane (8.25%) and Protein Binding (10.5%) 
considering, respectively, Biological Process, Cellular 
Components and Molecular Function categories. For 
the grown network after STRING database interactions 
analysis, the results were: Response to Stimulus (32.13%), 
Membrane (27.19%), Protein Binding (29.33%). At last, 
for the in common genes between the neuron-glia grown 
network and genes differentially expressed after a 2mM 
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Lithium treatment, the main related biological pathways 
were: Cell Proliferation (10.22%), Membrane (4.23%) and 
Protein Binding (5.56%). Therefore, biological pathways 
related to cellular membrane and protein binding function 
were found as main related with the pertinent genes for 
neuroprotection and neuronal-glia interaction and with the 
genes differentially expressed after a high dose of treatment 
with Lithium. 
In addition, there were no overlapping results 
between the different treatment doses of Lithium and 
genes linked to neuronal-glia interaction but only between 
these genes and 2mM of Lithium treatment. High doses, 
though, can influence the biological pathways related and 
low doses cannot.  
CONCLUSION
Genes with neuron-glia interaction were found in 
the literature but few of these genes were expressed in 
cultures treated with Lithium. Lithium presented a dose-
dependent effect: sub therapeutic doses showed little or no 
pathway related to neuroprotection. The project suggests 
that the therapeutic dose (2mM) is the only one that changes 
genes related to neuronal-glia interaction.
Role of the funding source: Funding for this project was provided by Fundação de Amparo à Pesquisa de São Paulo (FAPESP - 
2016/01302-9, 2018/08621-8).
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